PT1551977E - Activação local, selectiva, de membros da família de ligandos tnf de proteínas de fusão de ligando tnf nãoanticorpo, sistemicamente inactivas - Google Patents

Activação local, selectiva, de membros da família de ligandos tnf de proteínas de fusão de ligando tnf nãoanticorpo, sistemicamente inactivas Download PDF

Info

Publication number
PT1551977E
PT1551977E PT03753550T PT03753550T PT1551977E PT 1551977 E PT1551977 E PT 1551977E PT 03753550 T PT03753550 T PT 03753550T PT 03753550 T PT03753550 T PT 03753550T PT 1551977 E PT1551977 E PT 1551977E
Authority
PT
Portugal
Prior art keywords
tnf ligand
selective
members
fusion proteins
local activation
Prior art date
Application number
PT03753550T
Other languages
English (en)
Inventor
Klaus Pfizenmaier
Harald Wajant
Original Assignee
Klaus Pfizenmaier
Harald Wajant
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klaus Pfizenmaier, Harald Wajant filed Critical Klaus Pfizenmaier
Publication of PT1551977E publication Critical patent/PT1551977E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/642—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a cytokine, e.g. IL2, chemokine, growth factors or interferons being the inactive part of the conjugate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT03753550T 2002-10-14 2003-10-14 Activação local, selectiva, de membros da família de ligandos tnf de proteínas de fusão de ligando tnf nãoanticorpo, sistemicamente inactivas PT1551977E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10247755A DE10247755B4 (de) 2002-10-14 2002-10-14 Selektive, lokale Aktivierung von Mitgliedern der TNF-Rezeptorfamilie durch systemisch inaktive nicht-Antikörper-TNF-Liganden-Fusionsproteine

Publications (1)

Publication Number Publication Date
PT1551977E true PT1551977E (pt) 2011-07-26

Family

ID=32038617

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03753550T PT1551977E (pt) 2002-10-14 2003-10-14 Activação local, selectiva, de membros da família de ligandos tnf de proteínas de fusão de ligando tnf nãoanticorpo, sistemicamente inactivas

Country Status (11)

Country Link
US (1) US20050244370A1 (pt)
EP (1) EP1551977B1 (pt)
JP (1) JP2006502720A (pt)
AT (1) ATE507298T1 (pt)
AU (1) AU2003271721A1 (pt)
DE (2) DE10247755B4 (pt)
DK (1) DK1551977T3 (pt)
ES (1) ES2365691T3 (pt)
PT (1) PT1551977E (pt)
SI (1) SI1551977T1 (pt)
WO (1) WO2004035794A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004014983A1 (de) 2004-03-26 2005-10-20 Univ Stuttgart Rekombinante Polypeptide der Mitglieder der TNF Ligandenfamilie und deren Verwendung
WO2006105972A1 (en) * 2005-04-07 2006-10-12 Universite Libre De Bruxelles Transgenic organism expressing cd40l and uses thereof
CN101157729B (zh) * 2007-10-23 2011-01-12 南京大学 一种肿瘤坏死因子相关凋亡配体变体及其应用
US9931386B2 (en) * 2008-06-16 2018-04-03 Atsuo Ochi Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
PL391627A1 (pl) 2010-06-25 2012-01-02 Adamed Spółka Z Ograniczoną Odpowiedzialnością Przeciwnowotworowe białko fuzyjne
ES2545895T3 (es) 2010-12-03 2015-09-16 Adamed Sp. Z O.O. Proteína de fusión anticancerígena
PL219845B1 (pl) * 2011-01-05 2015-07-31 Adamed Spółka Z Ograniczoną Odpowiedzialnością Przeciwnowotworowe białko fuzyjne
US9822179B2 (en) 2011-04-01 2017-11-21 Universitat Stuttgart Recombinant TNF ligand family member polypeptides with antibody binding domain and uses therefor
PL394618A1 (pl) * 2011-04-19 2012-10-22 Adamed Spólka Z Ograniczona Odpowiedzialnoscia Przeciwnowotworowe bialko fuzyjne
GB201406705D0 (en) 2014-04-15 2014-05-28 Univ Liverpool Fusion proteins,polynucleotides,expression vectors, and their uses
JP2018510214A (ja) * 2015-03-03 2018-04-12 カール メディカル リミテッド 二重シグナル伝達タンパク質（ｄｓｐ）融合タンパク質、及び疾患を処置するためのその使用方法
TW201902935A (zh) * 2017-03-29 2019-01-16 開曼群島商瑞華藥業集團 蛋白質結合物
EP3606949A1 (en) 2017-04-06 2020-02-12 Universität Stuttgart Tumor necrosis factor receptor (tnfr) binding protein complex with improved binding and bioactivity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2245877C (en) * 1996-02-20 2013-09-03 Applied Research Systems Ars Holding N.V. Hybrid proteins which form heterodimers
DE19963859A1 (de) * 1999-12-30 2001-07-12 Apotech Res & Dev Ltd Bi- oder Oligomer eines Di-, Tri-, Quattro- oder Pentamers von rekombinanten Fusionsproteinen
DE10045592A1 (de) * 2000-09-15 2002-03-28 Klaus Pfizenmaier Ein Antikörper-TNF-TNF Inhibitor Fusionsprotein (TNF-Selektokin) als zielspezifisches Prozytokin zur Tumortherapie
DE10045591A1 (de) * 2000-09-15 2002-04-04 Klaus Pfizenmaier Ortsspezifische, antikörpervermittelte Aktivierung proapoptotischer Zytokine - AMAIZe (Antibody-Mediated Apoptosis Inducing Zytokine)
DE10122140A1 (de) * 2001-05-08 2002-11-28 Apotech Res & Dev Ltd Rekombinante Fusionsproteine und deren Trimere

Also Published As

Publication number Publication date
SI1551977T1 (sl) 2011-11-30
DK1551977T3 (da) 2011-07-25
WO2004035794A1 (de) 2004-04-29
ATE507298T1 (de) 2011-05-15
DE10247755A1 (de) 2004-04-22
AU2003271721A1 (en) 2004-05-04
ES2365691T3 (es) 2011-10-10
DE10247755B4 (de) 2006-01-19
EP1551977A1 (de) 2005-07-13
JP2006502720A (ja) 2006-01-26
EP1551977B1 (de) 2011-04-27
DE50313652D1 (de) 2011-06-09
US20050244370A1 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
PT1551977E (pt) Activação local, selectiva, de membros da família de ligandos tnf de proteínas de fusão de ligando tnf nãoanticorpo, sistemicamente inactivas
WO1999061469A3 (en) Prostate growth-associated membrane proteins
DK0970213T3 (da) Dödsdomæneholdig receptor
AU3774300A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
ATE446310T1 (de) An mhc-moleküle bindende tumor-assoziierte peptide
WO1999028462A3 (en) Polypeptides and nucleic acids encoding the same
EP1672070A3 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO1999063088A3 (en) Membrane-bound proteins and nucleic acids encoding the same
WO2000002996A3 (en) Recombinant constructs and systems for secretion of proteins via type iii secretion systems
ATE447583T1 (de) Polypeptide und dafür kodierende nukleinsäure
WO2001051635A3 (en) Novel stra6 polypeptides
AU1959001A (en) Histone deacetylase-8 proteins, nucleic acids, and methods of use
WO1999025832A8 (en) Toso
PT1366161E (pt) Anticorpo anatagonista anti-pro842
Wang et al. Selective isopeptide bond formation: coupling ubiquitin67–76 with histone 2A114–128 by use of the transfer active ester condensation technique
WO2000068376A8 (en) Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
WO2003076569A3 (en) Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
WO2005030798A3 (en) TNFαCONVERTING ENZYME INHIBITORY AGENTS AND STIMULATORY AGENTS-
EP1241179A3 (en) Human cornichon-like protein and nucleic acids encoding it
EP1251139A3 (en) Human mindin-like protein and nucleic acids encoding it
EP1241250A3 (en) Human dehydrogenase-like protein and nucleic acid encoding it
EP1659131A3 (en) Polypeptides and nucleic acids encoding the same
EP1612220A3 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1247817A3 (en) Human CD23-like protein and nucleic acids encoding it
EP1241252A3 (en) Human enteropeptidase-like protein and nucleic acids encoding it